Current therapy of patients with endometrial carcinoma: A critical review

Strahlentherapie und Onkologie

Volumn 188, Issue 1, 2012, Pages 12-20

  Marnitz, S ^a   Kohler C ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Endometrial cancer; Gynecological surgery; Laparoscopic surgery; Radiotherapy; Treatment

Indexed keywords

CARBOPLATIN; CISPLATIN; PACLITAXEL;

ABDOMINAL HYSTERECTOMY; ADJUVANT CHEMORADIOTHERAPY; BRACHYTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER RISK; CANCER STAGING; CANCER SURGERY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; EXTERNAL BEAM RADIOTHERAPY; FERTILITY; HUMAN; LAPAROSCOPIC SURGERY; LAPAROSCOPICALLY ASSISTED VAGINAL HYSTERECTOMY; LYMPHADENECTOMY; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PELVIS LYMPHADENECTOMY; PROGNOSIS; QUALITY OF LIFE; RADIATION DOSE; REVIEW; ROBOTIC ASSISTED HYSTERECTOMY; ROBOTICS; SENTINEL NODE TECHNIQUE; SURGICAL TECHNIQUE; TOTAL LAPAROSCOPIC HYSTERECTOMY; TREATMENT INDICATION; VAGINAL HYSTERECTOMY;

BRACHYTHERAPY; CHEMORADIOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; ENDOMETRIAL NEOPLASMS; FEASIBILITY STUDIES; FEMALE; HUMANS; HYSTERECTOMY; HYSTERECTOMY, VAGINAL; LAPAROSCOPY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; OMENTUM; ORGAN SPARING TREATMENTS; OVARIECTOMY; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; ROBOTICS; SENTINEL LYMPH NODE BIOPSY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84856352020     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-011-0004-0     Document Type: Review

References (80)

1. http://www.cdc.gov/obesity/data/trends. Accessed 07 November 2011
2. Bakkum-Gamez JN, Gonzales-Bosquet J, Laack NN et al (2008) Current issues in the management of endometrial cancer. Mayo Clin Proc 83:97-112
3. Kennedy AW, Austin JM, Look KY, Munger CB (2000) The Society of Gynecologic Oncologists task force study of endometrial cancer initial experience. Gynecol Oncol 79:379-388
4. Foley K, Lee RB (1990) Surgical complications of obese patients with endometrial carcinoma. Gynecol Oncol 39:171-174 (Pubitemid 20372407)
5. Chan JK, Lin YG, Monk BJ et al (2001) Vaginal hysterectomy as primary treatment of endometrial cancer in medically compromised women. Obstet Gynecol 97:707-711
6. Zorlu CG, Simsek T, Ari ES (2005) Laparoscopy or laparotomy for the management of endometrial cancer. JSLS 9:442-446
7. Tozzi R, Malur S, Koehler C, Schneider A (2005) Laparoscopy versus laparotomy in endometrial cancer: first analysis of survival of a randomized prospective study. J Minim Invasive Gynecol 12:130-136 (Pubitemid 40800367)
8. Fram KM (2002) Laparoscopically assisted vaginal hysterectomy versus abdominal hysterectomy in stage I endometrial cancer. Int J Gynecol Cancer 12:57-61 (Pubitemid 34202950)
9. Malzoni M, Tinelli R, Cosentino F et al (2009) Total laparoscopic hysterectomy versus abdominal hysterectomy with lymphadenectomy for early-stage endometrial cancer: a prospective randomized study. Gynecol Oncol 112:126-133
10. Zullo F, Palomba S, Falbo A et al (2009) Laparoscopic surgery vs laparotomy for early stage endometrial cancer: long-term data of a randomized controlled trial. Am J Obstet Gynecol 200:296.e1-296.e9
11. Janda M, Gebski V, Brand A et al (2010) Quality of live after total laparoscopic hysterectomy versus total abdominal hysterectomy for stage I endometrial cancer (LACE): a randomised trial. Lancet Oncol 11:772-780
12. Mourits MJ, Bijen CB, Arts HJ et al (2010) Safety of laparoscopy versus laparotomy in early-stage endometrial cancer: a randomized trial. Lancet Oncol 11:763-771
13. Walker JL, Piedmonte MR, Spirtos NM et al (2009) Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group study LAP2. J Clin Oncol 27:5331-5336
14. Martinez A, Querleu D, Leblanc E et al (2010) Low incidence of port-site metastases after laparoscopic staging of uterine cancer. Gynecol Oncol 118:145-150
15. Peiretti M, Zanagnolo V, Bocciolone L et al (2009) Robotic surgery: changing the surgical approach for endometrial cancer in a referral cancer center. J Minim Invasive Gynecol 16:427-431
16. Bell MC, Torgerson J, Seshadri-Kreaden U et al (2008) Comparison of outcomes and cost for endometrial cancer staging via traditional laparotomy, standard laparoscopy and robotic techniques. Gynecol Oncol 111:407-411
17. Tozzi R, Malur S, Köhler C, Schneider A (2005) Analysis of morbidity in patients with endometrial cancer: is there a commitment to offer laparoscopy. Gynecol Oncol 97:4-9 (Pubitemid 40403667)
18. Obermair A, Manolitsas TP, Leung Y et al (2005) Total laparoscopic hysterectomy versus total abdominal hysterectomy for obese women with endometrial cancer. Int J Gynecol Cancer 15:319-324 (Pubitemid 40396972)
19. Zullo F, Palomba S, Russo T et al (2005) A prospective randomized comparison between laparoscopic and laparotomic approaches in women with early stage endometrial cancer: a focus on the quality of live. Am J Obstet Gynecol 193:1344-1352 (Pubitemid 41395102)
20. Kornblith AB, Huang HQ, Walker JL et al (2009) Quality of live of patients with endometrial cancer undergoing laparoscopic international federation of gynecology and obstetrics staging compared with laparotomy: a Gynecologic Oncology Group study. J Clin Oncol 27:5337-5342
21. Sartori E, Gadducci A, Landoni F et al (2001) Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and adjuvant radiation therapy. Int J Gynecol Cancer 11:430-437 (Pubitemid 34024800)
22. Cohn DE, Woeste EM, Cacchio S et al (2007) Clinical and pathologic correlates in surgical stage II endometrial carcinoma. Obstet Gynecol 109:1062-1067 (Pubitemid 46685946)
23. Bristow RE, Zerbe MJ, Rosenshein NB et al (2000) Stage IVB endometrial cancer: the role of cytoreductive surgery and determinants of survival. Gynecol Oncol 78:85-91 (Pubitemid 30650336)
24. Ayhan A, Taskiran C, Celik C et al (2002) The influence of cytoreductive surgery on survival and morbidity in stage IVB endometrial cancer. Int J Gynecol Cancer 12:448-453
25. Barlin JN, Puri I, Bristow RE (2010) Cytoreductive surgery for advanced or recurrent endometrial cancer: a meta-analysis. Gynecol Oncol 118:14-18
26. Sato S, Itamochi H, Shimada M et al (2009) Preoperative and intraoperative assessment of depth of myometrial invasion in endometrial cancer. Int J Gynecol Cancer 19:884-887
27. Mazzon I, Corrado G, Masciullo V et al (2010) Conservative surgical management of stage IA endometrial carcinoma for fertility preservation. Fertil Steril 93:1286-1289
28. Chiva L, Lapuente F, Gonzales-Cortijo L et al (2008) Sparing fertility in young patients with endometrial cancer. Gynecol Oncol 111:101-104
29. Signorelli M, Caspani G, Bonazzi C et al (2009) Fertility-sparing treatment in young women with endometrial cancer or atypical complex hyperplasia: a prospective single-institution experience of 21 cases. BJOG 116:114-118
30. Lee TS, Kim JW, Kim TJ et al (2009) Ovarian preservation during the surgical treatment of early stage endometrial adenocarcinoma: unraveling a mystery. Gynecol Oncol 115:26-31
31. Selman TJ, Mann CH, Zamora J, Khan KS (2008) A systematic review of tests for lymph node status in primary endometrial cancer. BMC Womens Health 8:8 (Review)
32. Brocker KA, Alt DA, Eichbaum M et al (2011) Imaging of female pelvic malignancies regarding MRI, CT and PET/CT (Part 1). Strahlenther Onkol 187:611-618
33. Brocker KA, Alt DA, Eichbaum M et al (2011) Imaging of female pelvic malignancies regarding MRI, CT and PET/CT (Part 2). Strahlenther Onkol 187
34. Inubashiri E, Hata K, Kanenishi K et al (2009) Positron emission tomography with the glucose analog [F]-fluoro-2-deoxy-D-glucose for evaluating pelvic lymph node metastasis in uterine corpus cancer: comparison with CT and MRI findings. J Obstet Gynaecol Res 35:26-34
35. Signorelli M, Guerra L, Buda A et al (2009) Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases. Gynecol Oncol 115:231-235
36. Kitajima K, Murakami K, Yamasaki E et al (2008) Accuracy of 18 F-FDG PET/CT in detecting pelvic and paraaortic lymph node metastasis in patients with endometrial cancer. AJR Am J Roentgenol 190:1652-1658 (Pubitemid 351798544)
37. Horowitz NS, Dehdashti F, Herzog TJ et al (2004) Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer. Gynecol Oncol 95:546-551 (Pubitemid 39592519)
38. Kitajima K, Murakami K, Yamasaki E et al (2009) Accuracy of integrated FDG-PET/contrast-enhanced CT in detecting pelvic and paraaortic lymph node metastasis in patients with uterine cancer. Eur Radiol 19:1529-1536
39. Sironi S, Picchio M, Landoni C et al (2007) Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET/CT in the detection of recurrence. Eur J Nucl Med Mol Imaging 34:472-479 (Pubitemid 46426981)
40. Chan JK, Wu HW, Cheung MK et al (2007) The outcomes of 20.063 women with unstaged endometroid uterine cancer. Gynecol Oncol 106:282-288 (Pubitemid 47096660)
41. Smith DC, Macdonald OK, Lee CM, Gaffney DK (2008) Survival impact of lymph node dissection in endometrial adenocarcinoma: a surveillance, epidemiology and end result analysis. Int J Gynecol Cancer 18:255-261 (Pubitemid 351365216)
42. Todo Y, Kato H, Kaneuchi M et al (2010) Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet 375:1165-1172
43. Creasman WT, Odicino F, Maisonneuve P et al (2006) Carcinoma of the corpus uteri in 26th Annual report on the results of treatment in gynaecologic cancer. Int J Gynaecol Obstet 95(Suppl 1):S105-S143
44. Mariani A, Dowdy SC, Cliby WA et al (2008) Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 109:11-18
45. Chi DS, Barakat RR, Palayekar MJ et al (2008) The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometroid histology. Int J Gynecol Cancer 18:269-273 (Pubitemid 351365228)
46. ASTEC study group, Kitchener H, Swart AM, Qian Q et al (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trail): a randomised study. Lancet 373:125-136
47. Boronow RC (2008) Endometrial cancer and lymph node surgery: the spins continue - a case for reason. Gynecol Oncol 111:3-6
48. Seamon LG (2010) Lymphadenectomy for endometrial cancer: the controversy. Gynecol Oncol 117:6-8
49. Burke TW, Levenbeck C, Tornos C et al (1996) Intraabdomanl lymphatic mapping to direct selective pelvic and paraaortic lymphadenctomy in women with high risk endometrial cancer: result of a pilot study. Gynecol Oncol 62:169-173 (Pubitemid 26274795)
50. Shenfield CB, Pearcey RG, Ghosh S, Dundas GS (2009) The management of inoperable stage I endometrial cancer using intracavitary brachytherapy alone: a 20-year institutional review. Brachytherapy 8:278-283
51. Keys HM, Roberts JA, Brunetto VL et al (2004) A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 92:744-751 (Pubitemid 38251372)
52. Alektiar KM, Venkatraman E, Chi DS, Barakat RR (2005) Intravaginal Brachytherapy alone for intermediate risk endometrial cancer. Int J Radiat Oncol Biol Phys 62:111-117 (Pubitemid 40591931)
53. Cragun JM, Havrilesky LJ, Calingaert B et al (2005) Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol 23:3668-3675
54. Emons G, Hellriegel M, Hawighorst T, Emons G (2009) Modern therapy concepts for endometrial cancer. Pathologe 30:268-273
55. ASTEC study group, Kitchener H, Swart AM et al (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 373:125-136
56. Benedetti Panici P, Basile S, Maneschi F et al (2008) Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 100:1707-1716
57. Nout RA et al (2010) Vaginal Brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high intermediate risk (PORTEC-2): an open label, non-inferiority, randomised trial. Lancet 375:316-323
58. Aalders J, Abeler V, Kolstad P, Onsrud M (1980) Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical andhistopathologIc study of 540 patients. Obstet Gynecol 56:419-427 (Pubitemid 10018299)
59. Creutzberg CL, Putten WL van, Koper PC et al (2000) Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 355:1404-1411 (Pubitemid 30215963)
60. Scholten AN, Putten WL van, Beerman H et al (2005) Postoperative radiotherapy for Stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review. Int J Radiat Oncol Biol Phys 63:834-838 (Pubitemid 41400072)
61. Kong A, Johnson N, Cornes P et al (2007) Adjuvant radiotherapy for stage I endometrial cancer. Cochrane Database Syst Rev (2):CD003916 (Review)
62. Keys HM, Roberts JA, Brunetto VL et al (2004) A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 92:744-751 (Pubitemid 38251372)
63. Small W Jr, Du Bois A, Bhatnagar S et al (2009) Practice patterns of radiotherapy in endometrial cancer among Member Groups of the Gynecologic Cancer Intergroup. Int J Gynecol Cancer 19:395-399
64. Wright JD, Fiorelli J, Kansler AL et al (2009) Optimizing the management of stage II endometrial cancer: the role of radical hysterectomy and radiation. Am J Obstet Gynecol 200(4):419e1-419e7
65. Klopp AH, Jhingran A, Ramondetta L et al (2009) Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation. Gynecol Oncol 115:6-11
66. Hoekstra AV, Kim RJ, Small W Jr et al (2009) FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes. Gynecol Oncol 114:273-278
67. Randall ME, Filiaci VL, Muss H et al (2006) Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 24:36-44 (Pubitemid 46630491)
68. Bruner DW, Barsevick A, Tian C et al (2007) Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: a gynecologic oncology group study. Qual Life Res 16:89-100 (Pubitemid 46046740)
69. Morrow CP, Bundy BN, Homesley HD et al (1990) Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: a Gynecologic Oncology Group Study. Gynecol Oncol 36:166-171 (Pubitemid 20061279)
70. Susumu N, Sagae S, Udagawa Y et al (2008) Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Gynecol Oncol 108:226-233 (Pubitemid 350299451)
71. Greven K, Winter K, Underhill K et al (2006) Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer. Gynecol Oncol 103:155-159 (Pubitemid 44374683)
72. Hogberg T (2008) Adjuvant chemotherapy in endometrial carcinoma: overview of randomised trials. Clin Oncol (R Coll Radiol) 20:463-469
73. Hogberg T, Rosenberg P, Kristensen G et al (2007) A randomized phase-III study on adjuvant treatment with radiation (RT) ± chemotherapy (CT) in early-stage high-risk endometrial cancer (NSGO-EC-9501/EORTC 55991). J Clin Oncol Proc 25(Suppl):5503
74. Mundt AJ, Roeske JC, Lujan AE et al (2001) Initial clinical experience with intensity-modulated whole pelvis radiation therapy in patients with gynaecologic malignancies. Gynecol Oncol 82:446-456
75. Randall ME, Ibbott GS (2006) Intensity- modulated radiation therapy (IMRT) for gynaecologic cancers. Pitfalls, hazards, and cautions to be considered. Semin Radiat Oncol 16:138-143
76. Marnitz S, Stromberger C, Kawgan-Kagan M et al (2010) Helical tomotherapy in cervical cancer patients: simultaneous integrated boost concept: technique and acute toxicity. Strahlenther Onkol 186:572-579
77. Kumar S, Bryant CS, Shah JP et al (2008) ASCO-Abstract 2008. J Clin Oncol 26(Suppl):Abstract 5539
78. Welte B, Suhr P, Bottke D et al (2010) Second malignancies in high-dose areas of previous tumor radiotherapy. Strahlenther Onkol 186:174-179
79. Friedman LC, Abdallah R, Schluchter M et al (2011) Adherence to vaginal dilatation following high dose rate brachytherapy for endometrial cancer. Int J Radiat Oncol Biol Phys 80:751-757
80. Nout RA, Putter H, Jürgenliemk-Schulz IM et al (2009) Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial. J Clin Oncol 27:3547-3556